ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced ...
Insulet said its Omnipod 5 automated insulin delivery system has been cleared by the Food and Drug Administration for people with type 2 diabetes. The Acton, Mass.-based company said Monday the ...
(HealthDay News) — On Monday, the US Food and Drug Administration approved the Insulet Omnipod 5 insulin delivery system for patients with type 2 diabetes. It is the first such system for use by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback